Markus Ollert Selected Research

Markus Ollert Research Topics

Disease

45	Hypersensitivity (Allergy) 05/2024 - 07/2005
13	Asthma (Bronchial Asthma) 05/2024 - 08/2008
12	Anaphylaxis (Anaphylactic Shock) 01/2022 - 10/2004
11	COVID-19 10/2023 - 01/2020
10	Inflammation (Inflammations) 07/2022 - 09/2004
8	Atopic Dermatitis (Atopic Eczema) 01/2016 - 04/2007
6	Venom Hypersensitivity 01/2020 - 01/2010
5	Bites and Stings (Sting) 01/2020 - 04/2011
4	Allergic Rhinitis 05/2024 - 01/2020
4	Neoplasms (Cancer) 01/2022 - 08/2013
3	Food Hypersensitivity (Food Allergy) 10/2023 - 01/2020
3	Infections 07/2022 - 04/2011
2	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2023 - 09/2012
2	Peanut Hypersensitivity (Peanut Allergy) 12/2022 - 01/2020
2	red meat allergy 01/2022 - 01/2019
2	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 08/2013
2	Eczema 12/2011 - 10/2008
2	Skin Diseases (Skin Disease) 01/2010 - 10/2008
1	Glioma (Gliomas) 01/2024
1	Rhinitis 01/2023
1	Glioblastoma (Glioblastoma Multiforme) 01/2023
1	Clinical Deterioration 11/2022
1	Breakthrough Infections 07/2022
1	Pathologic Processes 03/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Gynecomastia 10/2020
1	Opioid-Related Disorders (Opiate Addiction) 01/2020
1	Pain (Aches) 01/2020
1	Drug Hypersensitivity (Drug Allergy) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	ZAP70 deficiency 01/2018
1	Diabetes Mellitus 01/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018

Drug/Important Bio-Agent (IBA)

33	Immunoglobulin E (IgE)IBA 01/2024 - 05/2007
25	AllergensIBA 10/2023 - 07/2005
12	Arthropod VenomsIBA 10/2021 - 07/2005
10	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2018
7	VenomsIBA 11/2021 - 01/2010
5	Proteins (Proteins, Gene)FDA Link 12/2022 - 04/2011
4	CarbohydratesIBA 01/2022 - 01/2010
3	OvalbuminIBA 10/2023 - 01/2010
3	Antiviral Agents (Antivirals)IBA 01/2022 - 08/2008
3	VaccinesIBA 01/2021 - 11/2012
3	AntibodiesIBA 01/2019 - 05/2007
2	N-(2-cyanoethylene)urea (BA 1)IBA 10/2023 - 07/2022
2	Neutralizing AntibodiesIBA 10/2023 - 07/2022
2	CytokinesIBA 10/2023 - 11/2022
2	Wasp Venoms (Venom, Wasp)IBA 01/2022 - 07/2011
2	COVID-19 VaccinesIBA 10/2021 - 01/2021
2	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 01/2018 - 08/2013
2	Carrier Proteins (Binding Protein)IBA 01/2018 - 07/2011
2	Bee Venoms (Bee Venom)IBA 10/2017 - 12/2016
2	Glutathione (Reduced Glutathione)IBA 01/2017 - 01/2017
2	anti-IgE antibodiesIBA 05/2011 - 11/2007
2	Myeloblastin (Proteinase 3)IBA 07/2008 - 09/2004
1	NexusIBA 01/2024
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 10/2023
1	Virulence Factors (Pathogenicity Factors)IBA 01/2023
1	Epidermal Growth Factor (EGF)IBA 11/2022
1	MicroRNAs (MicroRNA)IBA 11/2022
1	Interleukin-10 (Interleukin 10)IBA 11/2022
1	HydrogelsIBA 07/2022
1	Broadly Neutralizing AntibodiesIBA 07/2022
1	GlycolipidsIBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	EpitopesIBA 01/2022
1	Biotin (Vitamin H)FDA Link 01/2022
1	Immunoglobulin A (IgA)IBA 05/2021
1	ChemokinesIBA 03/2021
1	erucylphosphocholineIBA 01/2021
1	EndotoxinsIBA 01/2021
1	CPG-oligonucleotideIBA 01/2021
1	OligodeoxyribonucleotidesIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	P-2 (P 2)IBA 01/2021
1	Oxygen (Dioxygen)IBA 11/2020
1	AndrogensIBA 10/2020
1	Estrogens (Estrogen)FDA Link 10/2020
1	Monoclonal AntibodiesIBA 01/2020
1	ProteomeIBA 01/2020
1	Opioid Analgesics (Opioids)IBA 01/2020
1	Opioid Peptides (Opioid Peptide)IBA 01/2020
1	Opioid Receptors (Opioid Receptor)IBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	ParvalbuminsIBA 01/2019
1	anthraceneIBA 01/2018
1	matrigelIBA 01/2018
1	Autophagy-Related ProteinsIBA 01/2018
1	Immune Checkpoint InhibitorsIBA 01/2018
1	Blood Glucose (Blood Sugar)IBA 01/2018
1	CarcinogensIBA 01/2018

Therapy/Procedure

10	Immunotherapy 01/2022 - 12/2016
9	Therapeutics 12/2021 - 04/2007
2	Precision Medicine 10/2022 - 01/2020
1	Radiotherapy 01/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Injections 10/2021
1	Artificial Heart (Artificial Hearts) 01/2021
1	Aftercare (After-Treatment) 01/2021
1	Contraindications 01/2021